ePRO BI1403-0008 12+
ERT,INC
-
- Free
Screenshots
Description
The Boehringer Ingelheim ePRO App is intended to collect patient reported outcomes (BI Study 1403-0008)
Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.
What’s New
Version 2.10.5 (18)
Alignment of visit availability windows after Week 15. Ireland and South Korea removed as countries
App Privacy
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Information
- Seller
- ERT, INC
- Size
- 62.9 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 8.0 or later.
- iPad
- Requires iPadOS 8.0 or later.
- iPod touch
- Requires iOS 8.0 or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © 2022 ERT, Boehringer-Ingelheim
- Price
- Free